한국어
English
日本語
中文(简体)
Nexavar 200 mg Tablets (Sorafenib Tosylate (Unformulated))
274mg
Tablet · Prescription medication
Bayer Korea Co., Ltd.
Sorafenib tosylate is an active ingredient used in the treatment of malignant tumors.
MFDS ingredient code M257069
Sorafenib tosylate is an anticancer drug that belongs to the multi-kinase inhibitor class, used to inhibit the growth of cancer cells and angiogenesis. It is primarily utilized in the treatment of specific malignant tumors such as hepatocellular carcinoma and renal cell carcinoma.
This ingredient blocks the activity of specific enzymes within cancer cells, hindering the processes of cell proliferation and the formation of new blood vessels. This helps slow down or halt tumor growth.
Approved uses differ by product. Check each product's information for its actual use.
Sorafenib tosylate is a multi-target anticancer agent that inhibits multiple enzymes simultaneously, allowing it to block various cancer growth pathways unlike single-target drugs. It is formulated in a non-differentiated form to enhance absorption in the body.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.
